Current low global threat levels from monitored pathogens support the market's 84% implied probability against a new pandemic before 2028. Official CDC and WHO assessments show the Bundibugyo virus outbreak confined to parts of Africa with minimal U.S. importation risk, while H5N1 avian influenza causes only sporadic human cases without sustained human-to-human transmission. COVID-19 continues as a moderate-risk respiratory virus integrated into routine surveillance, with stable severity indicators and no variants driving major surges. Enhanced post-2020 genomic sequencing, wastewater monitoring, and international preparedness frameworks further reduce escalation likelihood, though experts note ongoing vigilance for reassortment events in influenza or mpox clade shifts remains essential.